Oxidized low-density lipoprotein: A double-edged sword on atherosclerosis

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 553-556

  Yu, Bi lian ^a   Zhao, Shui ping ^a   Huang, Xian sheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROTECTION; CHOLESTEROL TRANSPORT; FOAM CELL; HUMAN; IMMUNITY; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL;

ATHEROSCLEROSIS; FOAM CELLS; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL; MODELS, THEORETICAL; OXIDATION-REDUCTION; OXYGEN;

EID: 34447255926     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.043     Document Type: Article

References (28)

1. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141 (1998) 1-15
2. Jialal I., and Devaraj S. The role of oxidized low density lipoprotein in atherogenesis. J Nutr 126 (1996) 1053S-1057S
3. Heinecke J.W. Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?. J Exp Med 203 (2006) 813-816
4. Fraley A.E., and Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 17 (2006) 502-509
5. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 26 (2003) 1-9
6. Itabe H., Yamamoto H., Imanaka T., et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 37 (1996) 45-53
7. Tsimikas S., and Witztum J.L. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 103 (2001) 1930-1932
8. Nishi K., Itabe H., Uno M., et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 22 (2002) 1649-1654
9. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
10. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97 (1998) 2433-2444
11. Suzuki T., Kohno H., Hasegawa A., et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 35 (2002) 347-353
12. Johnston N., Jernberg T., Lagerqvist B., Siegbahn A., and Wallentin L. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol 97 (2006) 640-645
13. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
14. Levonen A.L., Dickinson D.A., Moellering D.R., Mulcahy R.T., Forman H.J., and Darley-Usmar V.M. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler Thromb Vasc Biol 21 (2001) 1846-1851
15. Ishikawa K., and Maruyama Y. Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. J Atheroscler Thromb 8 (2001) 63-70
16. Moellering D.R., Levonen A.L., Go Y.M., et al. Induction of glutathione synthesis by oxidized low-density lipoprotein and 1-palmitoyl-2-arachidonyl phosphatidylcholine: protection against quinone-mediated oxidative stress. Biochem J. 362 (2002) 51-59
17. Bea F., Hudson F.N., Chait A., Kavanagh T.J., and Rosenfeld M.E. Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements. Circ Res 92 (2003) 386-393
18. Gutierrez J., Ballinger S.W., Darley-Usmar V.M., and Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99 (2006) 924-932
19. Binder C.J., Chang M.K., Shaw P.X., et al. Innate and acquired immunity in atherogenesis. Nat Med 8 (2002) 1218-1226
20. Michelsen K.S., Wong M.H., Shah P.K., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101 (2004) 10679-10684
21. Bjorkbacka H., Kunjathoor V.V., Moore K.J., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10 (2004) 416-421
22. Frostegard J., Ulfgren A.K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 (1999) 33-43
23. Tupin E., Nicoletti A., Elhage R., et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199 (2004) 417-422
24. Shah P.K., Chyu K.Y., Fredrikson G.N., and Nilsson J. Immunomodulation of atherosclerosis with a vaccine. Nat Clin Pract Cardiovasc Med 2 (2005) 639-646
25. Ameli S., Hultgardh-Nilsson A., Regnstrom J., et al. Effect of immunization with homologous LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16 (1996) 1074-1079
26. Nilsson J., Calara F., Regnstrom J., et al. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon in hypercholesterolemic rabbits. J Am Coll Cardiol 30 (1997) 1886-1891
27. Freigang S., Horkko S., Miller E., Witztum J.L., and Palinski W. Immunization of LDL receptor deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18 (1998) 1972-1982
28. van Puijvelde G.H., Hauer A.D., de Vos P., et al. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 114 (2006) 1968-1976